Yes, children are investigated quite differently from adults when it comes to nephrotic syndrome. In the UK, the clinical approach is tailored to the most likely cause for each age group. Because the vast majority of children have a specific, highly treatable condition, their “diagnostic journey” is often simpler and less invasive initially than the path taken by adults.
Within the NHS, paediatricians and nephrologists follow age-specific guidelines. For children, the focus is often on a rapid trial of treatment, whereas for adults, the priority is a definitive diagnosis through detailed tissue analysis. Understanding these differences helps parents and adult patients manage their expectations and understand why their specialist may recommend a “wait-and-see” approach or an immediate, more invasive procedure.
What We’ll Discuss in This Article
- Why the “trial of treatment” is the standard first step for children.
- The role of the kidney biopsy: why it’s rare for kids but standard for adults.
- Differences in screening for secondary causes like diabetes and lupus.
- How UK specialists use “steroid response” as a diagnostic tool.
- When genetic testing becomes a priority in paediatric cases.
- Comparison of long-term monitoring requirements for different age groups.
The “Trial of Treatment” vs. Immediate Biopsy
The most significant difference in investigation is whether a kidney biopsy is performed at the start.
The Paediatric Approach
In the UK, about 90% of children with nephrotic syndrome have Minimal Change Disease. Because this condition almost always responds to steroids, a biopsy is usually avoided initially. Instead, children are started on a high-dose course of prednisolone (steroids). If the protein leak stops, the diagnosis of “Steroid-Sensitive Nephrotic Syndrome” is confirmed without ever needing a needle biopsy.
The Adult Approach
Adults are much more likely to have a variety of different kidney issues, such as Membranous Nephropathy or FSGS. Because the treatments for these can be complex and have more side effects, UK specialists rarely start treatment without a biopsy. A biopsy is the “gold standard” for adults to ensure they aren’t taking unnecessary or incorrect medications.
Screening for Secondary Causes
Another major difference lies in how much “detective work” is done to find an underlying disease.
- Children: Secondary causes (where another disease causes the kidney issue) are very rare in children. Aside from a few basic blood tests, specialists rarely perform extensive screening for things like cancer or chronic infections unless the child is very unwell or has atypical symptoms.
- Adults: Secondary causes are common in adults. A UK specialist will perform a wide “secondary screen,” testing for diabetes, hepatitis, HIV, and autoimmune conditions like Lupus. This is because treating the underlying disease is often the only way to stop the protein leak in an adult.
| Investigation Feature | Children (Typical) | Adults (Typical) |
| Initial Test | Urine dipstick and Bloods | Urine ACR, Bloods, and Biopsy |
| Kidney Biopsy | Only if steroids fail | Almost always performed early |
| Secondary Screening | Minimal | Extensive (Diabetes, Lupus, etc.) |
| Diagnostic Marker | Response to Steroids | Tissue pattern under microscope |
When Children Are Investigated Like Adults
There are specific “red flags” in a child’s presentation that will cause a UK paediatrician to move toward the more intensive investigation pathway usually reserved for adults.
A child will likely need a biopsy and more detailed screening if:
- They are very young: Infants under 12 months (Congenital Nephrotic Syndrome) often have genetic causes and need immediate biopsy and genetic testing.
- Atypical Features: They have high blood pressure, visible blood in the urine, or reduced kidney function (high creatinine) at the start.
- Steroid Resistance: The protein leak does not stop after 4 weeks of high-dose steroids.
Genetic Testing: A Focus for the Young
While genetic testing is rarely used for adults, it is a key investigative tool for specific paediatric cases. In the UK, if a child is “steroid-resistant,” the NHS Genomic Medicine Service may be used to look for mutations in genes like NPHS1 or NPHS2. Finding a genetic cause is vital because it tells the doctors that immunosuppressants likely won’t work, and the focus should shift to managing the kidneys until a transplant is possible.
To Summarise
Children are investigated differently from adults because their most common cause of nephrotic syndrome is highly predictable and responds well to steroids. Children often avoid a biopsy and extensive secondary screening, whereas adults require these tests early on to distinguish between multiple possible causes. By following these age-appropriate pathways, the NHS ensures that patients receive the most effective treatment with the least amount of invasive testing necessary.
If you experience severe, sudden, or worsening symptoms, such as difficulty breathing or extreme facial swelling, call 999 immediately.
Why isn’t my child having a biopsy?
In the UK, most children respond to steroids, making a biopsy unnecessary. If the steroids don’t work after a few weeks, your specialist will then discuss a biopsy.
Do adults ever skip the biopsy?
Rarely. Only if there is a clear secondary cause (like advanced diabetes) or if a specific blood test (like the PLA2R antibody) confirms a diagnosis without needing tissue.
Is genetic testing common for everyone?
No, it is mostly reserved for babies with the condition or children who do not respond to any standard medications.
How long do these investigations take?
Basic urine and blood tests take 24–48 hours. A biopsy result usually takes about a week, and genetic testing can take several weeks.
Will my child need more tests if they relapse?
Usually, a relapse is diagnosed with a simple home urine dipstick. More blood tests are only needed if the relapse is severe or doesn’t clear quickly.
Is the diagnosis the same if there’s blood in the urine?
If a child has significant blood in their urine, they are more likely to have a “nephritic” element, which usually triggers a more rapid investigation and biopsy.
Authority Snapshot
This article was reviewed by Dr. Stefan Petrov, a UK-trained physician with experience in general medicine and paediatric emergencies. The information provided aligns with NHS, BAPN, and NICE clinical guidance regarding the age-stratified management of glomerular diseases. Our goal is to help patients and families understand why clinical investigations are tailored to the specific risks and likelihoods associated with different age groups.
